Merck completes spinoff of women's health company Organon | 合法醫療器材資訊網

2021年6月4日—Merck(MSD)hascompletedthespinoffofOrganontoboostfocusongrowthareasandrealisehigherrevenueandearningspersharegrowth ...

Merck (MSD) has completed the spinoff of Organon to boost its focus on growth areas, realise higher revenue and earnings per share (EPS) growth rates.

Merck obtained a distribution of nearly $9bn from Organon as part of the spinoff.

As a separate company, Organon will now focus on enhancing women’s health and currently has a portfolio of approximately 60 treatments and products.

It caters to people in about 140 markets, with approximately 80% of its annual revenue of nearly $6.5bn generated outside the US.

With the launch, Organon will explore opportunities and collaborations across its women’s health and biosimilar products and established brands.

T...